Keyword: CMI 03/2016

Plant Construction & Process Technology

Diagnosis: Innovation Insufficiency – Treatment: Combination Therapy

12.09.2016 - Dear Readers, Since the beginning of the 21st century, pharma M&A activity has exploded. In addition to mergers and acquisitions, outsourcing of research and manufacturing has...

Logistics & Supply Chain

Pharmaceutical Logistics as a Brand

12.09.2016 - In recent years, pharmaceutical logistics has become a highly specialized discipline. This is why Marburg site operator Pharmaserv established a separate segment for the...

Plant Construction & Process Technology

Serialization – the Bigger Picture

12.09.2016 - Potency pills or even life-saving pharmaceuticals such as heparin – the trade with counterfeit medicine is still booming. Accordingly, drug producers and contract packers are...

Plant Construction & Process Technology

ISPE Recognizes Leaders in Drug Shortage Prevention

12.09.2016 - The International Society for Pharmaceutical Engineering (ISPE) recognized 2016 category winners Baxter BioPharma Solutions and Janssen Vaccines for their exceptional leadership in...

Plant Construction & Process Technology

Opportunities in Drug Development and Manufacturing

12.09.2016 -

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...

Strategy & Management

A New Pathway

12.09.2016 - Reducing nitro groups to amines is a well-known and frequently applied method, which is useful in the synthesis of various classes of compounds of interest in the pharmaceutical...

Plant Construction & Process Technology

The Possibilities Of Peptides

08.09.2016 - Peptides in pharmaceutical development have traveled a rough road. It took a long time for these small proteins to emerge as a basis for new medical products. This has become...

Plant Construction & Process Technology

Big Pharma Targets Aspiring Biotechs

08.09.2016 - There were 339 completed pharmaceutical deals in HY1 2016, an 11.5% increase compared to HY1 2015. Big pharma players were especially keen to strengthen their drug pipeline through...